Types of Cancer We Treat

Prostate Cancer

Our nationally and internationally known specialists offer comprehensive services that include the most up-to-date, research-backed approaches to prostate cancer screening, diagnosis, treatment, post-treatment rehabilitation, and integrative therapies.

Our doctors share in the growing consensus among top prostate cancer specialists that many men are being overtreated for prostate cancer. We work together to identify which men are best served by aggressive treatment and which can be treated safely with a more conservative approach. We believe in empowering you with information, so that you can be an active partner in creating a personalized treatment plan that’s right for you.

Meet Our Doctors
Dr. Herbert Lepor
Diagnosis
Prostate Cancer Diagnosis
Active Surveillance
Prostate Cancer Active Surveillance
Surgery
Prostate Cancer Surgery
Radiation Therapy
Prostate Cancer Radiation Therapy
Minimally Invasive Ablation Treatment
Prostate Cancer Minimally Invasive Ablation Treatment
Hormone Therapies & Other Systemic Therapies
Prostate Cancer Hormone Therapies & Other Systemic Therapies

Related News

Don’t Always Trust Medical Information from Online Videos
Read Story
Metastatic Prostate Cancer Treatment Is Improving
Read Story
Encouraging Findings for Patients Undergoing Prostatectomy
Read Story
Deciding When to Treat Prostate Cancer
Read Story

Clinical Trials and Research Studies

Phase 1

An Open-label Multicenter Phase 1b Study of JNJ-63723283 a PD-1 Inhibitor Administered in Combination with Apalutamide in Subjects with Metastatic Castration-Resistant Prostate Cancer

Learn More

Phase N/A

Prospective Multi-Center Study of the ClariCore TM Optical Biopsy System in Patients Undergoing Transperineal Prostate Biopsy for Prostate Tissue Classification Algorithm Development

Learn More

Phase 1/2

ProSTAR: A Phase 1b/2 Study of CPI-1205 a Small Molecule Inhibitor of EZH2 Combined with Enzalutamide or Abiraterone/Prednisone in Patients with Metastatic Castration Resistant Prostate Cancer

Learn More

Phase 1/2

A PHASE 1B/2 STUDY TO EVALUATE SAFETY AND ANTI-TUMOR ACTIVITY OF AVELUMAB IN COMBINATION WITH THE POLY (ADENOSINE DIPHOSPHATE [ADP]-RIBOSE) POLYMERASE (PARP) INHIBITOR TALAZOPARIB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS

Learn More
View All Related Clinical Trials (11)